Cannabinoid Receptor Agonists May Be Novel Class of Anti-Lymphoma Agents
http://www.pacifier.com/~alive/cmu/c…d_lymphoma.htm WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081675
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features. (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25594062
http://www.pacifier.com/~alive/cmu/c…d_lymphoma.htm WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081675
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features. (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25594062